Company Filing History:
Years Active: 2022-2025
Title: Matthew Kraman: Innovator in Cancer Therapy
Introduction
Matthew Kraman is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cancer therapy through his innovative work. With a total of 3 patents, Kraman has focused on developing specific binding members that target lymphocyte-activation gene 3 (LAG-3).
Latest Patents
Kraman's latest patents include advancements in LAG-3 binding members. These inventions relate to specific binding members that bind to LAG-3, which is crucial in cancer therapy. The specific binding members are designed to include a LAG-3 antigen-binding site, potentially located in two or more structural loops of a CH3 domain. This innovative approach aims to enhance the effectiveness of cancer treatments.
Career Highlights
Throughout his career, Matthew Kraman has worked with prominent companies in the biotechnology sector. Notable among these are F-star Therapeutics, Inc. and Invox Pharma Limited. His work in these organizations has allowed him to contribute to groundbreaking research and development in the field of cancer therapy.
Collaborations
Kraman has collaborated with several talented individuals in his field. Some of his notable coworkers include Mihriban Tuna and Francisca Wollerton Van Horck. These collaborations have further enriched his research and innovation efforts.
Conclusion
Matthew Kraman stands out as an influential inventor in the realm of cancer therapy. His innovative patents and collaborations reflect his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches in the fight against cancer.